Not currently recruiting at UCLA
QTX3034 in Patients With KRAS G12D Mutation
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at Los Angeles, California and other locations
- Dates
- study startedcompletion around
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- accepting new patients at some sites,
but this study is not currently recruiting here - Start Date
- Completion Date
- (estimated)
- Sponsor
- Quanta Therapeutics
- ID
- NCT06227377
- Phase
- Phase 1 Solid Tumor Research Study
- Study Type
- Interventional
- Participants
- Expecting 250 study participants
- Last Updated